Vaccine Tracker - eVacTraca System

In sub-Saharan Africa, fake drugs is a serious problem, the solution is to develop a system to counter fake COVID-19 vaccine distribution in Africa. 

The solution is to also create an intelligent automated database which monitors the distribution channel - pharmaceutical companies to the accredited COVID-19 suppliers/stores then to COVID-19 carriers the West Africa nations.

The solution is going to be based on Artificial Intelligent - database automation. 

The solution is expected to curb fake COVID-19 vaccines in Sub-Saharan Africa. It's expected to prevent deaths that could cause by counterfeit drugs. According to the London School of Hygiene and Tropical Medicine for the WHO - it says " fake drugs could cause 116,000 extra deaths from the disease every year in sub-Saharan Africa at a cost to patients and health systems of on average $38.5m a year" 

https://www.bbc.co.uk/news/world-africa-51122898

In Sub-Sahara Africa, fake drugs are common, the solution is to develop a system to counter fake COVID-19 vaccine distribution in West Africa sub-region.  

According to BBC, reports that - WHO estimates one out of every 10 medical products in low- and middle-income countries, which includes most of Africa, is sub-standard or fake. 
https://apps.who.int/iris/bitstream/handle/10665/326708/9789241513425-eng.pdf?ua=1

Furthermore, it states that Sub-Sahara Africa accounts for nearly half, 42% of global fake drugs according to the World Health Organization (WHO). 

https://www.bbc.co.uk/news/world-africa-51122898

https://www.bbc.co.uk/news/business-37470667

With COVID-19 pandemic the challenge of distributing a genuine vaccine from the pharmaceutical companies to the suppliers, eventually to the consumers is now double. That's majorly attributed to the fraudsters involving in counterfeit drugs who would take advantage of COVID-19 pandemic situation. 

Solving the problem DSL is developing a solution to help combating the fake drug distribution channel especially, by the time COVID-19 vaccine will be made available to Africa and Sub-Sahara Africa region.  

The solution is to also establish database which monitors the distribution channel - pharmaceutical companies to the accredited COVID-19 suppliers/stores then to COVID-19 carriers the West Africa nations.

The solution is intended to target 3 groups, main actors in the drug distribution ecosystem. 

1) Manufacturers of COVID-19 vaccine 

2) Accredited/approved suppliers/packagers of COVID-19 vaccine ( mainly West Africa based pharmaceutical firms, stores) 

3) COVID-19 carrier/agent who has tested positive of coronavirus 

The solution will address their need via the mobile phone; eVacTrac app will need to be downloaded by mobile user. Once installed a 4 digit code corresponding to an available COVID-19 vaccine in the database is generated for the issuance of physical medicine on the shelf. This will rule out fake COVID-19 vaccine in the market and reduce death rates. 

The problem is common across the West Africa sub-region, something that's really contributing to deaths, especially the vulnerable people. 

The solution is deplore-able, can be scaled regionally and globally. It relies on network services. 

The following are the known or existing competitors: 

1)  Sproxil is a US based company -  " builds trust across supply chains with mobile technology solutions that emphasize direct engagement from the factory through to the consumer"  https://sproxil.com/ 

2) mPedigree Network is a Ghana based firm  - "it uses mobile and web technologies in securing products against faking, counterfeiting and diversion" of drugs https://mpedigree.com/

DSL solution is different to the competitors because it offers exclusive Artificial Intelligence and Machine Learning approach using Robotic Automation Process (RPA) model. The RPA process model is centered on 4 major components: 1) People 2) Process 3) Governance 4) Technology/Tool.

DSL solution uses intelligent automation for its database and client application. Both the web portal and mobile app (eVacTraca) integrate with database to identify fake medicine. The existing competitors' solution models are not totally efficient because not every mobile phone user gets the time to scratch physical Bar-code and match it with mobile app. Also, criminals can easily exploit their solutions. 

eVacTraca process of identification of physical vaccine from manufacturer to supplier and end user is automated 

DSL solution is based on the Artificial Intelligence (AI) and Machine Learning (ML) approach using Robotic Automation Process (RPA) model. The RPA process model is centered on 4 major components: 1) People 2) Process 3) Governance 4) Technology/Tool.

eVacTraca process of identification of physical vaccine from manufacturer to supplier and end user is automated. 

eVacTraca architecture design is based on application engine which's written in Java and embeds python code that registers user's mobile phone number after installation. Once installed, it generate 4-digit code which's corresponding to a COVID-19 vaccine in the database. The 4-digit code will be shown to an accredited supplier/government agent to authenticate it via eVacTraca web portal and then issues a physical COVID-19 vaccine to the patient. eVacTrac model is unique, is a new technology which is going to be distinct to the existing competitors which based on physical scratching of medicine box for authentication.  

This solution is currently being developed by our software engineers, working to make it available by the end of 2020. There are just a few competitors which have already been in commercial use but their solutions do not have the unique technology advantage like ours. 

DSL solution is based on the Artificial Intelligence (AI) and Machine Learning (ML) approach using Robotic Automation Process (RPA) model. The RPA process model is centered on 4 major components: 1) People 2) Process 3) Governance 4) Technology/Tool.

This is solution is currently being developed by our software engineers, working to make it available by the end of 2020. There are just a few competitors which have already been in commercial use but their solutions do not have the unique technology advantage like ours. 

eVacTraca Solution Overview 

The solution is divided into 3 major parts integrated together as a whole system. 

a) Covid-19 vaccine Manufacturer 

b) Accredited Supplier/pharmacist/government agency 

c) COVID-19 patient 

There is web portal for part A & B and mobile app for eVacTraca for part C. eVacTraca will generate a code which will be matched with the vaccine to the  COVID-19 patient immediately he/she taps the app on their mobile phone. In addition, that will synchronization with the eVacTraca database which will be monitored by both the manufacturer and supplier/government agency. 

eVacTraca System Architecture Overview 

eVacTraca architecture design is based on application engine which's written in Java and embeds python code that registers user's mobile phone number after installation. 

Once installed, it generate 4-digit code which's corresponding to a COVID-19 vaccine in the database. 

The 4-digit code will be shown to an accredited supplier/government agent to authenticate it via eVacTraca web portal and then issues a physical COVID-19 vaccine to the patient. Immediately a vaccine is issued to a patient it sends confirmation to both the manufacturer(s) and/or accredited supplier/pharmacist. The number of vaccine in the database is deducted. 

Database comprises of the following tables

a) Covid-19 vaccine Manufacturer 

b) Accredited Supplier/pharmacist/government agency 

c) Installed eVacTraca on user's mobile phone with their number 

eVacTrac model is unique, is a new technology which is going to be distinct to the existing competitors which based on physical scratching of medicine box for authentication.  

The solution is being developed and going to be hosted in one of the public cloud provider in the United Kingdom. Dunne Services Limited (DSL) is expected to be incorporated in the United Kingdom, Nigeria and Ghana for full delivery of solution across the West Africa nations. 

DSL has embarked on the process of registration in Nigeria, Ghana to follow in 2021. 

The solution is user-centric based; it provides effective user interface to enable end-users easy navigation. 

The solution is user-centric based; it provides effective user interface to enable end-users easy navigation. 

We are looking at every possibility to make the solution robust, using Java and Python programming for easy design as well as to achieve the design objectives. 

There's Intellectual Property right to the system's architectural artifacts, catalog, database model design as well as code. 

The solution is user-centric based; it provides effective user interface to enable end-users easy navigation. 

eVacTraca solution is available in form of web portal and mobile app, for low connectivity environments and people in the remote areas. The mobile app - eVacTraca is deploy-able on  Android, Microsoft, iOS device users with low connectivity environments. 

First year, it will serve Nigeria then Ghana and expected to reach other West Africa countries in 3 years. It will serve millions of people in West Africa sub-region. 

Five years after, we are expecting to serve other Africa countries replicating the same model for other drugs. 

The goal is to expand solution to other Africa nations. To contribute to the development and building capacity. To also educate people on where to purchase drugs to treat diseases and how to guide against self-medication. 

First year, it will serve Nigeria then Ghana and expected to reach other West Africa countries in 3 years. It will serve millions of people in West Africa sub-region. 

Five years after, we are expecting to serve other Africa countries replicating the same model for other drugs. 

The main challenges is financial support needed to enable us penetrating the major towns, cities in the West African nations. There are millions of people in remote areas who have no access to healthcare services, many of them die without government supports, no access to standard medicines etc. 

The only method to overcome the challenge is to have funds and/or enough resources in order to be able to make this solution available to the poor and most vulnerable people in the rural areas. 

In addition, winning the Mission Billion Challenge would be the greatest achievement, as well as helping us meet the objectives of having this solution. The fund would help us hiring resources, provide training, visit the remote villages, towns so as to educate people of the harmful effects of fake medicines.   

Not applicable.

There are 3 people including myself working in our organization. 

1) Wale Bakare

I Co-founded, serve as CTO PAWAAK Technologies (established in 2010), operating in Nigeria. PAWAAK Technologies shortlisted for the Nigerian govt TechlaunchPad scheme in 2013. 

I am CEO/Principal Consultant Dunne Consulting Service Ltd (DSL) 

Technical Lead at DXC Technology, United Kingdom, 2018 - till date  

Technical Consultant, Electronics Business News (EBN), part of UBM Inc, 2010 - 2015

I also work as an Independent Consultant with GLG Inc. US 2011 - till date 

Education and Certification 

Wale Bakare’s admitted to study Business Sustainability course at the Harvard Business School, Harvard University, 2020 [ongoing]. 

Mr. Bakare obtained an MSc degree in Embedded Computer Systems Engineering from Northumbria University Newcastle upon Tyne, United Kingdom 2008. 

Wale also studied certificate course in Project Planning & Initiation at the University of California, Irvine, United States of America in 2016. 

Wale Bakare studied certificate course in User Innovation; focuses on Democratisation of Information at the Massachusetts Institute of Technology, United States of America in 2015 

2) Prasad Harischandra - Director of Software Development at Dunne Consult Service. He has BSc degree in Applied Computing at N'Umbria, Newcastle upon Tyne. 

3) Payne Adetoro - He's founder/Operating Officer at Smart Hedge Services, Lagos Nigeria.  Smart Hedge https://smartedgeservices.com/ is part of Dunne Consulting Services - http://www.dunconsult.com/about-page/

Payne is Director of Operations at Dunne Consult Services Limited.

Payne Adetoro educated at Lead City University, Ibadan, Nigeria to Diploma in Computer Science 

None 

Dunne Consult Services Limited is creating, developing and to deploy COVID-19 vaccine tracker; eVacTrac for Africans as free. DSL is seeking funding as well as supports in order to be able to achieve the purpose and objectives of vaccine tracker solution. 

DSL is seeking between $250,000 and $500,000 to cover hiring of personnel in Nigeria and Ghana. We are looking to hire 20 officers on a fixed-term of 24 months in Lagos, Nigeria; Accra Ghana. 

In addition, the funds will cover fixed costs and variable costs:

1) Fixed costs 2 years: 

     Salaries = $200,000.00

     Technology = $50,000.00

     Rent/utility/communications = $20,000.00

     Accounting = $30,000.00

2) Variable costs 2 years:

     Marketing = $20,000.00

     Packaging = $25,000.00

     Customer Service = $45,000.00

I am going to raise money to fund the project through donations and grants. In addition, I expect partnership with private entities as well as governmental organizations for supports. 

DSL will likely sell eVacTraca solution to organizations in healthcare industry, interested clients or third-parties. 

The long term goal is to offer yearly membership or subscription to the identified targets, particularly part A and Part B. 

We are still working on the solution whilst searching for organizations to provide supports. 

DSL is seeking funds between $250,000 and $500,000 to cover hiring of personnel, technology, accounting, Phone/communications, office space and other variable costs in Nigeria and Ghana for initial 2 years. 

1) Fixed costs 2 years: 

     Salaries = $200,000.00

     Technology = $50,000.00

     Rent/utility/communications = $20,000.00

     Accounting = $30,000.00

2) Variable costs 2 years:

     Marketing = $20,000.00

     Packaging = $25,000.00

     Customer Service = $45,000.00

eVacTraca process of identification of physical vaccine from manufacturer to supplier and end user is automated. 

The barrier to overcome is about educating and sensitize the end users, especially the poor and low educated ones on the use of mobile app. Winning the Mission Billion Challenge would assist in with hiring personnel both contract and permanent. 

I am going to raise money to fund the project through donations and grants. In addition, I expect partnership with private entities as well as governmental organizations for supports. 

DSL will likely sell eVacTraca solution to organizations in healthcare industry, interested clients or third-parties. 

The long term goal is to offer yearly membership or subscription to the identified targets, particularly part A and Part B. 

1) World Health Organization (WHO)

2) United Nations (UN) 

3) World Bank 

4) Pharmaceutical manufacturers such GSK, AstraZeneca/Oxford University, Pfizer, Sinovac, Moderna, Imperial College London, Johnson & Johnson 

5) Governments such Nigeria's NAFDAC, Ghana Health Service 

They can be of help by subscribing or partnering with us in order to reach out to the end users.